vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and ESSENTIAL PROPERTIES REALTY TRUST, INC. (EPRT). Click either name above to swap in a different company.

ESSENTIAL PROPERTIES REALTY TRUST, INC. is the larger business by last-quarter revenue ($158.8M vs $121.8M, roughly 1.3× Core Laboratories Inc.). ESSENTIAL PROPERTIES REALTY TRUST, INC. runs the higher net margin — 37.8% vs 4.2%, a 33.5% gap on every dollar of revenue. On growth, ESSENTIAL PROPERTIES REALTY TRUST, INC. posted the faster year-over-year revenue change (22.8% vs -1.4%). Over the past eight quarters, ESSENTIAL PROPERTIES REALTY TRUST, INC.'s revenue compounded faster (20.6% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Essential Properties Realty Trust is a publicly traded real estate investment trust (REIT) that acquires, owns and manages a diversified portfolio of single-tenant net-leased commercial properties across the United States. Its assets primarily cover essential service-oriented sectors including casual dining, automotive services, medical clinics, early childhood education centers and light industrial facilities, with tenants mostly holding robust long-term operating track records.

CLB vs EPRT — Head-to-Head

Bigger by revenue
EPRT
EPRT
1.3× larger
EPRT
$158.8M
$121.8M
CLB
Growing faster (revenue YoY)
EPRT
EPRT
+24.2% gap
EPRT
22.8%
-1.4%
CLB
Higher net margin
EPRT
EPRT
33.5% more per $
EPRT
37.8%
4.2%
CLB
Faster 2-yr revenue CAGR
EPRT
EPRT
Annualised
EPRT
20.6%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
EPRT
EPRT
Revenue
$121.8M
$158.8M
Net Profit
$5.1M
$60.0M
Gross Margin
Operating Margin
1.5%
56.5%
Net Margin
4.2%
37.8%
Revenue YoY
-1.4%
22.8%
Net Profit YoY
6.5%
EPS (diluted)
$0.11
$0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
EPRT
EPRT
Q1 26
$121.8M
$158.8M
Q4 25
$138.3M
$149.9M
Q3 25
$134.5M
$144.9M
Q2 25
$130.2M
$137.1M
Q1 25
$123.6M
$129.4M
Q4 24
$129.2M
$119.7M
Q3 24
$134.4M
$117.1M
Q2 24
$130.6M
$109.3M
Net Profit
CLB
CLB
EPRT
EPRT
Q1 26
$5.1M
$60.0M
Q4 25
$4.9M
$68.1M
Q3 25
$14.2M
$65.6M
Q2 25
$10.6M
$63.2M
Q1 25
$-154.0K
$56.1M
Q4 24
$7.4M
$55.4M
Q3 24
$11.7M
$49.1M
Q2 24
$9.0M
$51.5M
Gross Margin
CLB
CLB
EPRT
EPRT
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
EPRT
EPRT
Q1 26
1.5%
56.5%
Q4 25
11.5%
65.9%
Q3 25
15.6%
64.7%
Q2 25
11.7%
64.1%
Q1 25
3.6%
61.6%
Q4 24
11.0%
66.1%
Q3 24
14.7%
59.7%
Q2 24
12.3%
61.1%
Net Margin
CLB
CLB
EPRT
EPRT
Q1 26
4.2%
37.8%
Q4 25
3.6%
45.4%
Q3 25
10.6%
45.3%
Q2 25
8.2%
46.1%
Q1 25
-0.1%
43.4%
Q4 24
5.7%
46.3%
Q3 24
8.7%
42.0%
Q2 24
6.9%
47.1%
EPS (diluted)
CLB
CLB
EPRT
EPRT
Q1 26
$0.11
$0.28
Q4 25
$0.11
$0.34
Q3 25
$0.30
$0.33
Q2 25
$0.22
$0.32
Q1 25
$0.00
$0.29
Q4 24
$0.15
$0.31
Q3 24
$0.25
$0.27
Q2 24
$0.19
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
EPRT
EPRT
Cash + ST InvestmentsLiquidity on hand
$22.8M
$15.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$4.4B
Total Assets
$587.7M
$7.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
EPRT
EPRT
Q1 26
$22.8M
$15.2M
Q4 25
$22.7M
$60.2M
Q3 25
$25.6M
$23.8M
Q2 25
$31.2M
$20.8M
Q1 25
$22.1M
$47.0M
Q4 24
$19.2M
$40.7M
Q3 24
$21.5M
$32.7M
Q2 24
$17.7M
$23.6M
Total Debt
CLB
CLB
EPRT
EPRT
Q1 26
Q4 25
$110.3M
$2.5B
Q3 25
$114.1M
$2.6B
Q2 25
$124.6M
$2.3B
Q1 25
$124.4M
$2.1B
Q4 24
$126.1M
$2.1B
Q3 24
$139.9M
$2.2B
Q2 24
$147.6M
$1.9B
Stockholders' Equity
CLB
CLB
EPRT
EPRT
Q1 26
$275.1M
$4.4B
Q4 25
$266.0M
$4.2B
Q3 25
$271.3M
$3.8B
Q2 25
$261.3M
$3.8B
Q1 25
$253.4M
$3.8B
Q4 24
$246.6M
$3.6B
Q3 24
$250.7M
$3.2B
Q2 24
$240.3M
$3.2B
Total Assets
CLB
CLB
EPRT
EPRT
Q1 26
$587.7M
$7.2B
Q4 25
$584.0M
$6.9B
Q3 25
$591.4M
$6.6B
Q2 25
$602.1M
$6.3B
Q1 25
$591.5M
$6.1B
Q4 24
$585.1M
$5.8B
Q3 24
$600.5M
$5.5B
Q2 24
$597.8M
$5.3B
Debt / Equity
CLB
CLB
EPRT
EPRT
Q1 26
Q4 25
0.41×
0.60×
Q3 25
0.42×
0.69×
Q2 25
0.48×
0.61×
Q1 25
0.49×
0.56×
Q4 24
0.51×
0.60×
Q3 24
0.56×
0.69×
Q2 24
0.61×
0.59×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
EPRT
EPRT
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
EPRT
EPRT
Q1 26
$4.0M
Q4 25
$7.9M
$381.1M
Q3 25
$8.5M
$99.0M
Q2 25
$13.9M
$99.8M
Q1 25
$6.7M
$77.2M
Q4 24
$20.6M
$308.5M
Q3 24
$13.1M
$73.5M
Q2 24
$17.1M
$81.1M
Free Cash Flow
CLB
CLB
EPRT
EPRT
Q1 26
$517.0K
Q4 25
$5.0M
Q3 25
$6.5M
Q2 25
$10.4M
Q1 25
$3.9M
Q4 24
$17.4M
Q3 24
$10.4M
Q2 24
$14.3M
FCF Margin
CLB
CLB
EPRT
EPRT
Q1 26
0.4%
Q4 25
3.6%
Q3 25
4.8%
Q2 25
8.0%
Q1 25
3.1%
Q4 24
13.4%
Q3 24
7.7%
Q2 24
10.9%
Capex Intensity
CLB
CLB
EPRT
EPRT
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
2.7%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
2.0%
Q2 24
2.2%
Cash Conversion
CLB
CLB
EPRT
EPRT
Q1 26
0.77×
Q4 25
1.61×
5.60×
Q3 25
0.60×
1.51×
Q2 25
1.31×
1.58×
Q1 25
1.38×
Q4 24
2.78×
5.57×
Q3 24
1.12×
1.50×
Q2 24
1.90×
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

EPRT
EPRT

Rental revenue 1,2$149.4M94%
Other$8.6M5%
Other revenue$779.0K0%

Related Comparisons